Thursday, November 21, 2013

Hologic adopts poison pill after Icahn reports stake

File photograph of Investor Carl Icahn speaking at the Wall Street Journal Deals & Deal Makers conference at the New York Stock Exchange (Reuters) - Activist investor Carl Icahn disclosed a 12.63 percent stake in medical device maker Hologic Inc, prompting the company to adopt a shareholder rights plan to protect itself from hostile takeovers. Shares of Hologic, which makes screening tests for cancer and other diseases, rose 3 percent in late morning trading. Icahn, who has a track record of taking big stakes in companies and pushing for management change, said in a filing with the U.S. Securities and Exchange Commission that he believed Hologic's shares were undervalued. He also said he would consider discussing with Hologic's management the possibility of board representation and ways to improve shareholder value.








via Health News Headlines - Yahoo! News http://news.yahoo.com/hologic-adopts-poison-pill-icahn-reports-stake-160218446--sector.html

No comments:

Post a Comment